<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05045469</url>
  </required_header>
  <id_info>
    <org_study_id>202101000A3</org_study_id>
    <nct_id>NCT05045469</nct_id>
  </id_info>
  <brief_title>Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea</brief_title>
  <official_title>Therapeutic Effects of Topical Herbal Medicine on Rosacea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effects of topical herbal medicine in the&#xD;
      patients with rosacea.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rosacea is a chronic inflammatory disorder which affects the cheek, nose, chin, forehead and&#xD;
      eyes. It is typically characterized by cutaneous signs such as flushing, erythema,&#xD;
      telangiectasia, papules, and pustules in the face. The pathogenic mechanism of rosacea is&#xD;
      unknown, and there is no cure for rosacea. The therapeutic approaches include oral medicine,&#xD;
      topical medicine and surgical interventions depending on the different subtypes of rosacea.&#xD;
      The recent study demonstrates that combination therapy may be more effectively improved the&#xD;
      symptoms of rosacea. Dian dao san is a topical herbal compound for reducing the features as&#xD;
      flushing, erythema, papules, and pustules for years. The investigators hypothesize that dian&#xD;
      dao san can be more beneficial in treating the patients with rosacea and improving the&#xD;
      quality of life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 4, 2021</start_date>
  <completion_date type="Anticipated">August 4, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 4, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of flushing, erythema, telangiectasia, papules, and pustules</measure>
    <time_frame>6 weeks</time_frame>
    <description>quantified by Investigator Global Assessment, IGA. IGA is used in the study for assessing the severity of rosacea ranging from 0 (clean) to 4 (most severe).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>absence of adverse skin reaction to topical medicine</measure>
    <time_frame>6 weeks</time_frame>
    <description>scored with Dyshidrotic Eczema Area and Severity Index (DASI index). The total score of the DASI results from the sum of severity grade score points of each of the four items (V = vesicles, E = erythema, S = desquamation, I = itch) multiplied by the affected area (A) score points: DASI = (pV + pE + pS + pI) Ã— pA.&#xD;
The maximum possible score is 60. By the DASI, the dyshidrotic eczema is graded as: mild (0-15), moderate (16-30) and severe (31-60).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement of life quality</measure>
    <time_frame>6 weeks</time_frame>
    <description>Dermatology Quality of Life Index, DQoL is the questionnaire which designed to measure the health-related quality of life of adult patients suffering from a skin disease ranging from 0(no effect at all on patient's life) to 30(extremely large effect on patient's life).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Rosacea</condition>
  <condition>Chinese Herbal Medicine</condition>
  <arm_group>
    <arm_group_label>group A (dian dao san group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Herbal medicine (dian dao san) will be applied to the lesions of rosacea twice a day. Subject will receive persistent treatment for 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B( topical medicine without therapeutic effects)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (topical medicine without therapeutic effects) will be applied to the lesions of rosacea twice a day. Subject will receive persistent treatment for 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dian dao san</intervention_name>
    <description>dian dao san and placebo will be used in the rosacea lesions twice a day for 6 weeks</description>
    <arm_group_label>group A (dian dao san group)</arm_group_label>
    <arm_group_label>group B( topical medicine without therapeutic effects)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing to sign inform consent&#xD;
&#xD;
          -  Aged above 20 years old with rosacea&#xD;
&#xD;
          -  No treatment for rosacea within 2 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  With malignant lesion in the rosacea lesion&#xD;
&#xD;
          -  Rosacea lesion with high risk of infection&#xD;
&#xD;
          -  Allergy to Chinese herbal medicine patch or ointment&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YUAN-CHIEH YEH, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>YUAN-CHIEH YEH, Doctor</last_name>
    <phone>24313131</phone>
    <phone_ext>2127</phone_ext>
    <email>b9005030@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>HUAN-HSUAN HSU, Doctor</last_name>
    <phone>24313131</phone>
    <phone_ext>2127</phone_ext>
    <email>emilyhsu224@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keelung Chang Gung Memorial Hospital</name>
      <address>
        <city>Keelung</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YUAN-CHIEH YEH</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 7, 2021</study_first_submitted>
  <study_first_submitted_qc>September 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rosacea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

